• Mechanical Circulatory Support ▸

MCS plays a key role in Methodist Heart and Lung Institute’s advanced heart failure and cardiac transplant program. The latest devices offer improvements to quality of life as well as survival and include portable and implantable options. MCS can help patients optimize cardiac function and provide a bridge to transplant.

The program’s volume and quality attract industry sponsored MCS device trials to Methodist Heart and Lung Institute. This gives the team more treatment options, enabling customized care for end-stage heart failure patients. The hospital’s current MCS capabilities include more left ventricular assisted device (LVAD) options than anyone else in South Texas. In January 2021, Methodist Heart and Lung Institute became the first in the nation to implant the newly designed cardiac mechanical pump, EVAHEART®2.

The MCS program engages with the interdisciplinary advanced heart failure and cardiac transplant team, collaborating closely with ECMO and cardiogenic shock specialists as well as cardiologists, intensivists, cardiac surgeons, and many others.

IMPELLA VOLUME

97

78 92

2019 2020 2021